SURGERY PARTNERS INC (SGRY) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:SGRY • US86881A1007

14.86 USD
+0.38 (+2.62%)
At close: Jan 30, 2026
14.86 USD
0 (0%)
After Hours: 1/30/2026, 8:18:42 PM
Fundamental Rating

3

Taking everything into account, SGRY scores 3 out of 10 in our fundamental rating. SGRY was compared to 103 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of SGRY while its profitability can be described as average. SGRY is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year SGRY was profitable.
  • SGRY had a positive operating cash flow in the past year.
  • SGRY had negative earnings in each of the past 5 years.
  • SGRY had a positive operating cash flow in each of the past 5 years.
SGRY Yearly Net Income VS EBIT VS OCF VS FCFSGRY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

  • SGRY has a Return On Assets (-2.16%) which is in line with its industry peers.
  • SGRY has a Return On Equity of -9.94%. This is comparable to the rest of the industry: SGRY outperforms 44.66% of its industry peers.
  • SGRY has a Return On Invested Capital (5.57%) which is comparable to the rest of the industry.
  • SGRY had an Average Return On Invested Capital over the past 3 years of 5.03%. This is below the industry average of 9.16%.
  • The last Return On Invested Capital (5.57%) for SGRY is above the 3 year average (5.03%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -2.16%
ROE -9.94%
ROIC 5.57%
ROA(3y)-1.04%
ROA(5y)-1.46%
ROE(3y)-4.24%
ROE(5y)-9.69%
ROIC(3y)5.03%
ROIC(5y)4.49%
SGRY Yearly ROA, ROE, ROICSGRY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

1.3 Margins

  • SGRY's Operating Margin of 15.78% is amongst the best of the industry. SGRY outperforms 93.20% of its industry peers.
  • In the last couple of years the Operating Margin of SGRY has remained more or less at the same level.
  • With a Gross Margin value of 26.57%, SGRY perfoms like the industry average, outperforming 56.31% of the companies in the same industry.
  • In the last couple of years the Gross Margin of SGRY has remained more or less at the same level.
Industry RankSector Rank
OM 15.78%
PM (TTM) N/A
GM 26.57%
OM growth 3Y3.68%
OM growth 5Y1.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.83%
GM growth 5Y-0.73%
SGRY Yearly Profit, Operating, Gross MarginsSGRY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

2

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SGRY is destroying value.
  • Compared to 1 year ago, SGRY has more shares outstanding
  • SGRY has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for SGRY is higher compared to a year ago.
SGRY Yearly Shares OutstandingSGRY Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
SGRY Yearly Total Debt VS Total AssetsSGRY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • Based on the Altman-Z score of 0.75, we must say that SGRY is in the distress zone and has some risk of bankruptcy.
  • SGRY's Altman-Z score of 0.75 is on the low side compared to the rest of the industry. SGRY is outperformed by 71.84% of its industry peers.
  • The Debt to FCF ratio of SGRY is 18.37, which is on the high side as it means it would take SGRY, 18.37 years of fcf income to pay off all of its debts.
  • SGRY has a Debt to FCF ratio (18.37) which is in line with its industry peers.
  • A Debt/Equity ratio of 2.00 is on the high side and indicates that SGRY has dependencies on debt financing.
  • SGRY's Debt to Equity ratio of 2.00 is on the low side compared to the rest of the industry. SGRY is outperformed by 72.82% of its industry peers.
Industry RankSector Rank
Debt/Equity 2
Debt/FCF 18.37
Altman-Z 0.75
ROIC/WACC0.63
WACC8.79%
SGRY Yearly LT Debt VS Equity VS FCFSGRY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

  • A Current Ratio of 1.88 indicates that SGRY should not have too much problems paying its short term obligations.
  • SGRY has a better Current ratio (1.88) than 77.67% of its industry peers.
  • A Quick Ratio of 1.72 indicates that SGRY should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.72, SGRY is in the better half of the industry, outperforming 72.82% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.88
Quick Ratio 1.72
SGRY Yearly Current Assets VS Current LiabilitesSGRY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

  • The earnings per share for SGRY have decreased strongly by -17.02% in the last year.
  • SGRY shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.14%.
  • Measured over the past years, SGRY shows a quite strong growth in Revenue. The Revenue has been growing by 11.20% on average per year.
EPS 1Y (TTM)-17.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-31.58%
Revenue 1Y (TTM)10.14%
Revenue growth 3Y11.86%
Revenue growth 5Y11.2%
Sales Q2Q%6.63%

3.2 Future

  • Based on estimates for the next years, SGRY will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.89% on average per year.
  • The Revenue is expected to grow by 7.88% on average over the next years.
EPS Next Y-29.92%
EPS Next 2Y-10.69%
EPS Next 3Y0.93%
EPS Next 5Y12.89%
Revenue Next Year6.88%
Revenue Next 2Y7.52%
Revenue Next 3Y7.62%
Revenue Next 5Y7.88%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SGRY Yearly Revenue VS EstimatesSGRY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B 4B
SGRY Yearly EPS VS EstimatesSGRY Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 1 -1 -2

4

4. Valuation

4.1 Price/Earnings Ratio

  • SGRY is valuated rather expensively with a Price/Earnings ratio of 19.05.
  • Based on the Price/Earnings ratio, SGRY is valued a bit cheaper than the industry average as 72.82% of the companies are valued more expensively.
  • SGRY is valuated rather cheaply when we compare the Price/Earnings ratio to 28.30, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 19.82, SGRY is valued on the expensive side.
  • Based on the Price/Forward Earnings ratio, SGRY is valued a bit cheaper than the industry average as 61.16% of the companies are valued more expensively.
  • The average S&P500 Price/Forward Earnings ratio is at 25.57. SGRY is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 19.05
Fwd PE 19.82
SGRY Price Earnings VS Forward Price EarningsSGRY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SGRY indicates a somewhat cheap valuation: SGRY is cheaper than 77.67% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, SGRY is valued cheaply inside the industry as 86.41% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 9.91
EV/EBITDA 8.13
SGRY Per share dataSGRY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 -20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-10.69%
EPS Next 3Y0.93%

0

5. Dividend

5.1 Amount

  • No dividends for SGRY!.
Industry RankSector Rank
Dividend Yield 0%

SURGERY PARTNERS INC / SGRY FAQ

Can you provide the ChartMill fundamental rating for SURGERY PARTNERS INC?

ChartMill assigns a fundamental rating of 3 / 10 to SGRY.


What is the valuation status for SGRY stock?

ChartMill assigns a valuation rating of 4 / 10 to SURGERY PARTNERS INC (SGRY). This can be considered as Fairly Valued.


How profitable is SURGERY PARTNERS INC (SGRY) stock?

SURGERY PARTNERS INC (SGRY) has a profitability rating of 4 / 10.


What is the financial health of SURGERY PARTNERS INC (SGRY) stock?

The financial health rating of SURGERY PARTNERS INC (SGRY) is 2 / 10.


What is the earnings growth outlook for SURGERY PARTNERS INC?

The Earnings per Share (EPS) of SURGERY PARTNERS INC (SGRY) is expected to decline by -29.92% in the next year.